Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Assets Average (2019 - 2025)

Historic Assets Average for Exagen (XGN) over the last 7 years, with Q3 2025 value amounting to $60.8 million.

  • Exagen's Assets Average rose 3085.82% to $60.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.8 million, marking a year-over-year increase of 3085.82%. This contributed to the annual value of $50.8 million for FY2024, which is 2900.99% down from last year.
  • Latest data reveals that Exagen reported Assets Average of $60.8 million as of Q3 2025, which was up 3085.82% from $49.5 million recorded in Q2 2025.
  • In the past 5 years, Exagen's Assets Average ranged from a high of $135.4 million in Q2 2021 and a low of $42.5 million during Q1 2025
  • Over the past 5 years, Exagen's median Assets Average value was $71.7 million (recorded in 2023), while the average stood at $82.0 million.
  • As far as peak fluctuations go, Exagen's Assets Average skyrocketed by 6399.24% in 2021, and later tumbled by 3998.16% in 2023.
  • Over the past 5 years, Exagen's Assets Average (Quarter) stood at $125.6 million in 2021, then fell by 25.24% to $93.9 million in 2022, then crashed by 37.24% to $58.9 million in 2023, then fell by 25.09% to $44.1 million in 2024, then skyrocketed by 37.7% to $60.8 million in 2025.
  • Its Assets Average stands at $60.8 million for Q3 2025, versus $49.5 million for Q2 2025 and $42.5 million for Q1 2025.